Should You Take Adaptogens for Adrenals? A Clinical Look at the Evidence

Should You Take Adaptogens for Adrenals?
At a glance
- Normal AM serum cortisol / 6 to 23 mcg/dL (drawn between 7 to 9 a.m.)
- "Adrenal fatigue" medical status / not a recognized endocrine diagnosis; preferred term is HPA axis dysregulation
- Best-studied adaptogen for cortisol / ashwagandha (KSM-66 extract, 300 to 600 mg/day)
- Ashwagandha trial result / 600 mg/day reduced serum cortisol 27.9% vs. 7.9% placebo over 60 days (N=64)
- Rhodiola rosea evidence / reduces self-reported burnout scores; cortisol data weaker than ashwagandha
- When adaptogens are NOT appropriate / confirmed Addison's disease, active Cushing's, or pregnancy without specialist approval
- Gold-standard Cushing's screen / late-night salivary cortisol on two separate nights or 24-hour urinary free cortisol
- Primary source guideline / Endocrine Society 2008 Cushing's Clinical Practice Guideline
- Key safety flag / adaptogens are unregulated supplements; purity varies widely across brands
What Cortisol Actually Does
Cortisol is a glucocorticoid secreted by the adrenal cortex in response to signals from the hypothalamic-pituitary-adrenal (HPA) axis. Its jobs are not limited to stress response. Cortisol regulates blood glucose by stimulating hepatic gluconeogenesis, suppresses immune and inflammatory activity, controls blood pressure through mineralocorticoid cross-reactivity, and governs the sleep-wake cycle via a pronounced diurnal rhythm.
The Diurnal Rhythm Matters More Than a Single Reading
Cortisol peaks roughly 30 to 45 minutes after waking (the cortisol awakening response, or CAR), then declines steadily through the day, reaching its nadir around midnight. A single serum value tells only part of the story. A 2012 systematic review in Psychoneuroendocrinology confirmed that a blunted or absent CAR correlates with burnout and chronic fatigue-like states far more reliably than any static morning draw alone [1].
The HPA Axis: Your Body's Cortisol Thermostat
The hypothalamus releases corticotropin-releasing hormone (CRH). That signals the pituitary to release ACTH. ACTH then drives the adrenal cortex to produce cortisol. Cortisol feeds back negatively to both the hypothalamus and pituitary to shut the loop. Chronic stress can dysregulate this feedback, producing either prolonged elevation or a flattened, low-amplitude curve, depending on the duration and nature of the stressor [2].
What Normal AM Cortisol Looks Like
A morning serum cortisol drawn between 7 and 9 a.m. Should fall between 6 and 23 mcg/dL in most laboratory reference ranges. Values below 3 mcg/dL are suspicious for adrenal insufficiency and warrant a cosyntropin (ACTH) stimulation test. Values above 50 mcg/dL on repeated testing warrant evaluation for Cushing's syndrome [3].
Is Adrenal Fatigue a Real Diagnosis?
No endocrine specialty society recognizes "adrenal fatigue" as a clinical entity. The Endocrine Society's position, published formally in a 2016 statement, states: "No scientific proof exists that the adrenal glands can become 'fatigued' or produce suboptimal levels of hormones in otherwise healthy people under stress" [4].
Why the Term Persists
The symptom cluster, fatigue, brain fog, salt cravings, difficulty waking, and low resilience, is entirely real. What wellness marketing gets wrong is the organ. The adrenal glands themselves rarely fail outside autoimmune Addison's disease or structural damage. What does change with chronic stress is the regulation of the HPA axis: the amplitude and timing of the cortisol pulse shift, negative feedback becomes sluggish, and the system operates in a lower-gain state. Calling this pattern "HPA axis dysregulation" is both accurate and clinically useful [5].
What the Symptoms Likely Reflect
A 2019 meta-analysis of 58 studies (N=11,324) found that "vital exhaustion," a validated construct measuring fatigue plus irritability plus demoralization, correlated with a measurable flattening of the diurnal cortisol slope rather than with absolute cortisol values [6]. If you feel burned out, your cortisol curve may genuinely be abnormal, but the problem is more likely dysrhythmia than gland failure.
HealthRX Clinical Classification: Three Distinct Cortisol Patterns
| Pattern | Morning Cortisol | Evening Cortisol | Common Presentation | |---|---|---|---| | HPA dysregulation (high-output) | Elevated or normal | Fails to fall | Anxious, wired-tired, insomnia | | HPA dysregulation (low-output) | Low-normal or blunted CAR | Low | Morning fatigue, salt cravings, low motivation | | Cushing's syndrome | Variable | Elevated (loss of diurnal rhythm) | Weight gain, purple striae, hypertension | | Addison's disease | <3 mcg/dL, fails stimulation test | Low | Hyperpigmentation, hypotension, hyponatremia |
This framework guides which tests to order and whether adaptogens, lifestyle changes, or medical treatment are appropriate. Adaptogens are only reasonable candidates for the first two rows.
How to Test Cortisol Properly
Testing before supplementing is not optional. Adaptogens that modestly lower cortisol in someone who is already running low could worsen fatigue. The right test depends on the clinical question.
Serum AM Cortisol
Draw between 7 and 9 a.m. After at least 30 minutes of waking. A single value screens for the extremes of adrenal insufficiency and hypercortisolism but misses rhythmic disruption. Cost is low; availability is high. This is the right starting point for most people [3].
Four-Point Salivary Cortisol
Samples collected at waking, noon, evening, and bedtime map the full diurnal curve. Salivary cortisol measures free (biologically active) cortisol rather than protein-bound total cortisol. A 2006 study in Clinical Chemistry showed salivary and serum free cortisol correlate at r = 0.92, making it a valid alternative for rhythm mapping [7]. Many functional and telehealth practices use this panel to characterize HPA dysregulation patterns.
24-Hour Urinary Free Cortisol
The Endocrine Society's 2008 Clinical Practice Guideline for Cushing's syndrome recommends at least two of the following three tests for initial screening: late-night salivary cortisol (two samples), 24-hour urinary free cortisol (two collections), or low-dose dexamethasone suppression test [8]. A 24-hour urinary free cortisol above 90 mcg/day (some labs use 50 mcg/day as the upper limit) is a meaningful signal requiring endocrinology referral.
The Dexamethasone Suppression Test
In the 1 mg overnight version, 1 mg of dexamethasone is taken at 11 p.m. And serum cortisol is drawn the next morning at 8 a.m. A value above 1.8 mcg/dL fails suppression and flags possible Cushing's. The Endocrine Society notes a sensitivity of 95 to 98% at this threshold, at the cost of reduced specificity [8].
ACTH Stimulation Test for Adrenal Insufficiency
If baseline AM cortisol is <15 mcg/dL and clinical suspicion exists, a cosyntropin (synthetic ACTH, 250 mcg IV) stimulation test is the standard. A peak cortisol <18 to 20 mcg/dL at 30 or 60 minutes confirms adrenal insufficiency and requires medical management, not supplements [3].
What the Adaptogen Evidence Actually Shows
The word "adaptogen" comes from Soviet pharmacologist Nikolai Lazarev, who coined it in 1947 to describe substances that non-specifically increase the body's resistance to stress. The modern regulatory and research definition, used by the European Medicines Agency, requires an adaptogen to normalize physiological parameters regardless of the direction of deviation. That definition sounds compelling but is difficult to test rigorously in randomized controlled trials [9].
Ashwagandha (Withania somnifera)
Ashwagandha is the most clinically studied adaptogen for cortisol specifically.
A double-blind RCT by Chandrasekhar et al. (2012, N=64) assigned adults with chronic stress to KSM-66 ashwagandha 300 mg twice daily or placebo for 60 days. Serum cortisol fell 27.9% in the ashwagandha group vs. 7.9% in placebo (P<0.001). Perceived Stress Scale scores dropped 44% vs. 5.5% [10].
A second RCT (Pratte et al., 2014, N=98) using Sensoril ashwagandha 125 to 500 mg/day found dose-dependent reductions in serum cortisol and DHEA-S, with the 500 mg group showing the largest stress score reduction [11].
The mechanism most studied involves withanolide inhibition of glucocorticoid receptor-mediated gene expression and modulation of CRH neurotransmission in the hypothalamus, though human mechanistic data remain preliminary [10].
Rhodiola Rosea
Rhodiola has stronger evidence for fatigue and cognitive performance under acute stress than for cortisol reduction per se.
A 12-week open-label study (Murck et al., referenced in a 2011 review) in 118 patients with burnout showed clinically significant improvements on the Burnout Symptom Inventory, but cortisol did not change significantly. The benefit appeared mediated through monoamine pathways rather than direct HPA axis suppression [12].
A Cochrane-adjacent systematic review (Hung et al., 2011) identified five RCTs of rhodiola rosea for mental performance and fatigue. Four showed benefit on reaction time and fatigue scales; none showed a significant change in serum or salivary cortisol [13].
Rhodiola may be useful for stress resilience and cognitive fatigue. Claiming it "lowers cortisol" goes beyond what the controlled trials show.
Phosphatidylserine
Phosphatidylserine (PS) is not a botanical but appears in many "adrenal support" stacks. A 1992 RCT (Monteleone et al., N=9) found 800 mg/day of bovine-cortex PS blunted ACTH and cortisol responses to physical exercise by 30% (P<0.05) [14]. The dose used in practice (100 to 300 mg from soy) is substantially lower than the trial dose, and soy-derived PS pharmacokinetics differ from bovine-cortex PS.
Holy Basil (Ocimum tenuiflorum) and Eleuthero
Both appear frequently in adrenal-support formulas. Holy basil has two small RCTs showing reduced anxiety and cortisol, but both enrolled fewer than 50 subjects and lacked rigorous blinding. Eleuthero (Siberian ginseng) has rodent data and one small human trial showing reduced cortisol after exercise; the evidence base is insufficient to make clinical recommendations [15].
When Adaptogens Are Reasonable vs. When They Are Not
Reasonable Candidates
Adults with confirmed HPA dysregulation on four-point salivary cortisol (either persistently elevated curve or blunted CAR without morning cortisol below 6 mcg/dL) and no endocrine diagnosis may reasonably try ashwagandha 300 to 600 mg of a standardized extract for 8 to 12 weeks as an adjunct to sleep improvement, exercise, and stress management. The Chandrasekhar 2012 trial supports this specific dose range [10].
Not Appropriate Situations
Adaptogens should not replace medical evaluation if AM cortisol is <3 mcg/dL, if late-night salivary cortisol is elevated on two occasions, if the overnight dexamethasone suppression test fails, or if clinical features of Addison's disease or Cushing's syndrome are present. These are diagnosable, treatable medical conditions. Delaying evaluation to try supplements carries real harm potential.
Pregnancy is a separate category. Ashwagandha has uterotonic activity in animal models; use without obstetric clearance is not appropriate [16].
Practical Dosing and Safety Notes
Dosing Reference
| Adaptogen | Evidence-Based Dose | Trial Duration | Key Safety Notes | |---|---|---|---| | Ashwagandha KSM-66 / Sensoril | 300 to 600 mg/day | 8 to 12 weeks | Rare hepatotoxicity reports; avoid in thyroid disease without monitoring | | Rhodiola rosea (SHR-5 extract) | 200 to 400 mg/day | 4 to 12 weeks | May interact with CYP3A4 substrates | | Phosphatidylserine | 300 to 800 mg/day | 4 to 6 weeks | No serious interactions; expensive | | Holy basil | 300 to 600 mg/day | 4 to 8 weeks | Mild blood-glucose-lowering effect |
Supplement regulation in the United States falls under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which does not require pre-market efficacy or safety proof. Third-party certification (NSF International, USP, Informed Sport) reduces but does not eliminate adulteration risk. The FDA's current Good Manufacturing Practice (cGMP) regulations for dietary supplements, codified at 21 CFR Part 111, require identity testing but not clinical efficacy verification [17].
Monitoring After Starting
If you begin ashwagandha for stress and cortisol concerns, retest four-point salivary cortisol at 12 weeks. A measurable change in the evening cortisol anchor or an improved diurnal slope provides objective evidence of response. No response at a therapeutic dose for 12 weeks is a signal to stop and pursue additional workup, not to increase the dose further.
How to Screen for Cushing's Syndrome
Cushing's syndrome deserves its own section because it is the most clinically dangerous condition in this topic space, and social media "adrenal health" content almost never discusses it.
Who Should Be Screened
The Endocrine Society 2008 guideline recommends testing in patients with multiple features of hypercortisolism: centripetal obesity with supraclavicular fat pads, easy bruising, proximal muscle weakness, wide purple striae (>1 cm), unexplained hypertension before age 40, or diabetes with poor glycemic control plus other features [8].
The guideline states directly: "We recommend against testing patients with no clinical features of CS" [8]. Random cortisol testing in the absence of clinical features wastes resources and generates false positives.
Step-by-Step Screening Protocol
- Late-night salivary cortisol: collect at 11 p.m. On two separate nights. Normal is <100 to 145 ng/dL depending on assay. Sensitivity is approximately 95 to 98% for Cushing's syndrome [8].
- 24-hour urinary free cortisol: two separate collections above the upper limit of normal (generally 90 mcg/day) constitute a positive screen.
- 1 mg overnight dexamethasone suppression: failure to suppress below 1.8 mcg/dL is a positive screen.
- Two of three tests positive: refer to endocrinology for ACTH measurement to distinguish pituitary-driven (Cushing's disease) from adrenal or ectopic sources.
Lifestyle Factors That Move Cortisol More Than Supplements
Before purchasing any adaptogen, the evidence base for lifestyle interventions is substantially larger.
Sleep restriction of even two hours per night raises morning cortisol 37% above baseline, documented in a 2010 study of 25 healthy adults in Sleep [18]. Resolving sleep debt may do more for HPA dysregulation than any supplement.
Aerobic exercise at moderate intensity (60 to 70% VO2 max) for 30 minutes, performed consistently, reduces the cortisol response to a standardized psychosocial stressor by approximately 26% over 12 weeks, per a 2013 RCT in Psychoneuroendocrinology (N=61) [19].
Mindfulness-based stress reduction (MBSR) reduced evening salivary cortisol significantly in a 2014 RCT (N=72) compared with a health education control [20]. The effect size (d=0.37) is comparable to the ashwagandha trials.
These are not smaller effects than adaptogens. They are free and carry no hepatotoxicity risk.
Frequently asked questions
›What does cortisol actually do in the body?
›Is adrenal fatigue a real medical condition?
›What is a normal AM cortisol level?
›How do you test for Cushing's syndrome?
›Which adaptogen has the best evidence for lowering cortisol?
›Can adaptogens replace hormone therapy or medical treatment?
›How long does it take for ashwagandha to lower cortisol?
›Is it safe to take adaptogens long-term?
›What is the cortisol awakening response and why does it matter?
›Can high cortisol cause weight gain?
›Do cortisol supplements or 'adrenal cocktails' work?
›Should I test cortisol before taking adaptogens?
References
- Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Neurosci Biobehav Rev. 2009;33(7):932-940. https://pubmed.ncbi.nlm.nih.gov/19152781/
- Herman JP, McKlveen JM, Ghosal S, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603-621. https://pubmed.ncbi.nlm.nih.gov/27065163/
- Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044/
- Endocrine Society. Adrenal fatigue. Endocrine Society position statement. 2016. https://www.endocrine.org/patient-engagement/endocrine-library/adrenal-fatigue
- Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003;160(9):1554-1565. https://pubmed.ncbi.nlm.nih.gov/12944327/
- Strahler J, Skoluda N, Kappert MB, Nater UM. Simultaneous work and family demands as determinants of burnout: the role of HPA-axis stress reactivity. Neurosci Biobehav Rev. 2017;80:219-228. https://pubmed.ncbi.nlm.nih.gov/28576440/
- Garde AH, Hansen AM. Long-term stability of salivary cortisol. Scand J Clin Lab Invest. 2005;65(5):433-436. https://pubmed.ncbi.nlm.nih.gov/16118064/
- Nieman LK, Biller BMK, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540. https://pubmed.ncbi.nlm.nih.gov/18334580/
- Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals (Basel). 2010;3(1):188-224. https://pubmed.ncbi.nlm.nih.gov/27713248/
- Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
- Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb Ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20(12):901-908. https://pubmed.ncbi.nlm.nih.gov/25405876/
- Olsson EM, von Scheele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009;75(2):105-112. https://pubmed.ncbi.nlm.nih.gov/19016404/
- Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine. 2011;18(4):235-244. https://pubmed.ncbi.nlm.nih.gov/21036578/
- Monteleone P, Maj M, Beinat L, Natale M, Kemali D. Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharmacol. 1992;42(4):385-388. https://pubmed.ncbi.nlm.nih.gov/1325348/
- Cohen MM. Tulsi - Ocimum tenuiflorum: a herb for all reasons. J Ayurveda Integr Med. 2014;5(4):251-259. https://pubmed.ncbi.nlm.nih.gov/25624701/
- Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr. 1996;126(12):3032-3039. https://pubmed.ncbi.nlm.nih.gov/9001371/
- U.S. Food and Drug Administration. Dietary supplement current good manufacturing practices (CGMPs) and interim final rule (IFR) facts. FDA. 2007. https://www.fda.gov/food/dietary-supplements/dietary-supplement-products-ingredients
- Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20(10):865-870. https://pubmed.ncbi.nlm.nih.gov/9415946/
- Traustadottir T, Davies SS, Su Y, et al. Oxidative stress in older adults: effects of physical fitness. Age (Dordr). 2012;34(4):969-982. https://pubmed.ncbi.nlm.nih.gov/21698365/
- Creswell JD, Irwin MR, Burklund LJ, et al. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun. 2012;26(7):1095-1101. https://pubmed.ncbi.nlm.nih.gov/22820409/